By Femtech Insider Biotech, News, Oncology, Pelvic Health, Women's Health April 23, 2021 ShareTwitterFacebookPinterest-circled Roche Receives FDA Approval for the First Companion Diagnostic to Identify Endometrial Cancer Patients Eligible for Immunotherapy
By Femtech Insider Biotech, News, Reproductive Health April 19, 2021 ShareTwitterFacebookPinterest-circled Mayne Pharma’s Receives FDA Approval for NEXTSTELLIS, a New Oral Contraceptive Containing E4, the First New Estrogen Introduced in the U.S. in 50 Years
By Femtech Insider Biotech, Career, News, Partnership, Women's Health April 6, 2021 ShareTwitterFacebookPinterest-circled Dr. Adrienne Day Joins Women’s Health Biotech Celmatix’s Strategic Advisory Board
By Femtech Insider Biotech, Digital Health, Investment, Maternal Health, News, Partnership, Women's Health April 5, 2021 ShareTwitterFacebookPinterest-circled Merck’s Women’s Health Spinoff Organon Announces the Acquisition of Maternal Health Company Alydia Health
By Femtech Insider Biotech, Menopause, News April 1, 2021 ShareTwitterFacebookPinterest-circled Bonafide Brings Innovation to the Menopause Space With New Non-Drug Solutions
By Femtech Insider Biotech, Menopause, News March 22, 2021 ShareTwitterFacebookPinterest-circled Daré Bioscience Completes Recruitment in Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring for the Treatment of Vasomotor Symptoms and Genitourinary Syndrome Associated with Menopause
By Femtech Insider Biotech, News, Reproductive Health, Women's Health March 6, 2021 ShareTwitterFacebookPinterest-circled Mayne Pharma Launches A Generic Version of ORTH-CEPT, an Oral Contraceptive, in the U.S.
By Femtech Insider Biotech, Partnership, Pelvic Health, Reproductive Health, Women's Health February 17, 2021 ShareTwitterFacebookPinterest-circled Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health